A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer

Research output: Contribution to journalEditorialOtherpeer-review


PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019. J. Cell Biol. https://doi.org/10.1083/jcb.201902048) surprisingly show that the AKT-suppressing phosphatase PHLPP2 promotes disease progression in the context of dual PTEN and p53 loss by increasing MYC stability.
Original languageEnglish
Pages (from-to)1771-1772
Number of pages2
JournalJournal of Cell Biology
Issue number6
Publication statusPublished - 3 Jun 2019

Cite this